Cohort: 2024
Country: Uganda
Focus Area: Global Immunology and Immune Sequencing for Epidemic Response(GIISER)
Global Immunology and Immune Sequencing for Epidemic Response (GIISER) is envisioned as a collection of geographically distinct sites that can pair their local pathogen sequencing surveillance and clinical epidemiology with local immunological understanding and tools. Prof Kaleebu studies the characterization of circulating SARS CoV-2 variants to inform timely public health responses; these include the molecular, antigenic, and immune profiling and response to vaccines. His work has been applied to other emerging infections, such as Ebola virus infection and Rift Valley Fever. The project has contributed to scientific studies of B-cell receptor analyses and monoclonal antibody generation at UVRI and has been used in training and collaborations.